"The European Medicines Agency (EMA) has approved mepolizumab (Nucala, GlaxoSmithKline) as an add-on treatment for severe refractory eosinophilic asthma in adults in the 31 European countries covered by the EMA, according to a company state"...
DOSAGE AND ADMINISTRATION
The recommended dosage of ZYFLO CR for the treatment of patients with asthma is two 600 mg extended-release tablets twice daily, within one hour after morning and evening meals, for a total daily dose of 2400 mg. Tablets should not be chewed, cut or crushed. If a dose is missed, the patient should take the next dose at the scheduled time and not double the dose. Assess hepatic function enzymes prior to initiation of ZYFLO CR and periodically during treatment [see CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS and Use in Specific Populations].
Dosage Forms and Strengths
Extended-release tablets, 600 mg.
ZYFLO CR (zileuton) extended-release tablets are debossed on one side with "CT2"; they are available in bottles of 120 tablets (NDC 10122-902-12) and as samples in bottles of 20 tablets (NDC 10122-902-20). Store between 20 and 25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Protect from light.
Manufactured for: Cornerstone Therapeutics Inc. Gary, NC 27518. Revised: 11/2011This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 12/12/2011
Additional Zyflo CR Information
Zyflo CR - User Reviews
Zyflo CR User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.